ArticleAdvances in therapy2023

Cost-Effectiveness Analysis of Toripalimab Plus Paclitaxel and Cisplatin as First-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma.

Rui Fang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.